KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Royalty Pharma (RPRX) over the last 4 years, with Q3 2025 value amounting to $924.6 million.

  • Royalty Pharma's Goodwill & Intangibles changed N/A to $924.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $924.6 million, marking a year-over-year change of. This contributed to the annual value of $5.7 million for FY2021, which is 8022.05% down from last year.
  • Latest data reveals that Royalty Pharma reported Goodwill & Intangibles of $924.6 million as of Q3 2025.
  • In the past 5 years, Royalty Pharma's Goodwill & Intangibles ranged from a high of $924.6 million in Q2 2025 and a low of $5.7 million during Q4 2021